Rigel Pharmaceuticals | RIGL - Текущие обязательства





Текущие обязательства Изменить Дата
Agenus USD 231.82M 17.42M 2026-06
Amgen USD 25.5B 547M 2026-06
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Celldex Therapeutics USD 61.32M 9.85M 2026-06
Daiichi Sankyo JPY 765.7B 119.32B 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
MacroGenics USD 108.82M 12.88M 2026-06
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Veracyte USD 62.74M 6.62M 2026-06